• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharma Supply Chains: From Fragile to Agile

    Advanced Manufacturing and a Roadmap to the Facility of the Future

    Solving Pharma’s Underlying Rebate Leakage Problem

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Revolutionizing Pharma’s Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    "3 Key Trends" with Srinivasan Shanmugam
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Pharmaceutical Continuous Manufacturing: USP Technical Guide

    Mikart Expands Production and Packaging Capabilities

    Flavor Masking for Rx and OTC Drugs

    Prefilled Syringe Production: Filling a Need with Modern Equipment

    Making the Complex, Simple: A Roadmap for Your OSD Journey
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Modern Partnerships with CROs

    Merck KGaA, Quris-AI Expand Collaboration

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval

    Aurisco's Manufacturing Site in China Clears FDA Inspection

    LighthouseAI Secures $2.25M Investment to Grow Supply Chain Products

    Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Quotient Sciences

    AMERIPHARMA

    Bachem

    Federal Equipment Company

    TaiMed Biologics
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Quotient Sciences

    AMERIPHARMA

    Bachem

    Federal Equipment Company

    TaiMed Biologics
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Expert's Opinion

    Opportunity Knocks for Inhalers in Emerging Markets

    As key drugs and delivery devices come off-patent emerging markets offer potential for inhaled generics

    Opportunity Knocks for Inhalers in Emerging Markets
    Dr. Anselm Ebert, Global Business Development Manager, H&T Presspart06.05.17

    There is no disputing that respiratory disease is on the rise, with asthma and chronic obstructive pulmonary disease (COPD) in particular representing a significant worldwide burden. Globally, 300 million people have asthma, a figure which is set to rise to 400 million by 2025, and it is responsible for 250,000 deaths globally each year, of which 90% are preventable.

     

    Furthermore, with key drugs and delivery devices soon to come off-patent in the asthma and COPD space, it is predicted that the emerging markets offer considerable potential for inhaled generics. Asia Pacific is expected to display the fastest growth, driven by the rapidly-evolving healthcare industry that has led to an increasing patient pool in need of treatments for asthma and COPD. 

     

    India in particular is expected to benefit from the increasing efforts from its government to reduce overall healthcare costs. The country has seen the rise of the middle class with more disposable income, as have a number of nations in Latin America, Middle East and Africa, who are seeing improved access to healthcare – one of the positive results of rapid urbanization.

     

    This has led to the increased usage of asthma inhalers in these regions and while the inhaled market has been dominated by metered dose inhalers (MDIs), the dry powder inhaler (DPI) has become the fastest-growing segment. 

     

    However, while most DPIs have been designed for developed markets, with multiple components and complex mechanics, the demand for respiratory treatments is also growing rapidly in developing markets.  Interestingly, the message from the customers I speak to is that while they want DPIs that can deliver reliable performance, they also need to be easy to use and come at a reduced cost. 

     

    While the pharmaceutical industry has made extraordinary technological advances with inhalation devices, it is also important to make sure that we are not also adding complexity that makes them more difficult to use and expensive to make - manufacturers must not lose sight of the importance of device usability as well as functionality.
     


     
     


    A well-designed inhaler which is easy to use can help remove the risk of errors that may affect a treatment’s efficacy and one of them - poor inhaler technique - is still a huge problem. A 2016 large independent study summarized 144 articles reporting on 54,354 subjects and concluded that “incorrect inhaler technique is unacceptably frequent and has not improved over the past 40 years, pointing to an urgent need for new approaches to education and drug delivery”1. Earlier this month, the Asthma Society of Ireland unveiled figures which show that up to 60% of the 300,000 asthmatics in the country do not have their disease under control 2.

     

    Those figures are from a European country and the statistics from developing markets are equally concerning. In Latin America, COPD deaths have increased by 65% in the last decade and in India, a study collecting data without spirometry assessment suggested that 12 million people were affected by the disease - in China, chronic respiratory diseases are the second leading cause of death. 

     

    There is clearly unmet medical need in the developing markets and a major opportunity for generic manufacturers of respiratory medicines. DPIs represent the strongest opportunity for these markets, especially capsule-based DPIs, which offer significant cost and flexibility benefits. However, while cost is clearly an important factor, companies looking to tap into this market need to be able to deliver quality product guarantees. 

     

    H & T Presspart has over 45 years’ heritage in the assembly and manufacture of respiratory drug delivery components, producing parts for over 75% of the world’s MDIs.  This year we have moved into the DPI space through a pact with Portugal’s Hovione and launched PowdAir Plus, which is designed principally for the developing world.

     

    PowdAir Plus, a capsule-based DPI,  was designed to maximize simplicity and ease of use and to minimize manufacturing assembly and production costs, for example with no metal and separate parts, and was designed to be robust to withstand the mechanical stresses of frequent use. A particularly novel design feature is the way the device opens the capsule once the tray is closed, removing the need for patients to actively pierce the capsule and reducing the number of operational steps. 

     

    However, being easy to use and efficacious is not enough for medical devices nowadays - it has to look good too and that applies to inhalers in both developed and emerging markets. 

     

    A decade ago, the focus was on functionality but as the industry becomes more customer-focused, the importance of aesthetics has grown. If patients are going to use a tool all the time, it has to look nice and be neat and portable. Essentially, to tick all the boxes requires real design discipline. 

     

    The generic DPI segment in developing markets shows a lot of promise for manufacturers who provide products that meet the needs of patients and payers in those countries. Affordable manufacturing and assembly are a prerequisite for success, but don’t make the mistake of cutting costs at the expense of quality and design.  Expectations are changing and patients, payers and healthcare professionals don’t want inferior products. It may cost less than a mature-market equivalent, but it has to serve the purpose just as well. That means making it simple to use, easy to carry, robust and reliable – and great to look at.
     


    References
    1 Joaquin Sanchis, Ignasi Gich, and Soren Pedersen, Aerosol Drug Management Improvement Team (ADMIT), CHEST 2016; 150(2): 394
    2 https://www.asthma.ie/news/300000-irish-asthmatics-not-using-inhalers-correctly-world-asthma-day-asthma-week-2017

    Related Searches
    • it
    • production
    • asia pacific
    • Manufacturing
    Suggested For You
    CPhI North America Travel CPhI North America Travel
    Exothera Names Darren Leva as Chief Business Officer Exothera Names Darren Leva as Chief Business Officer
    Symbiosis Completes Successful MHRA Audit Symbiosis Completes Successful MHRA Audit
    AGC Biologics Expands pDNA and mRNA Manufacturing Capacity AGC Biologics Expands pDNA and mRNA Manufacturing Capacity
    Tekni-Plex Reorganizes Business Structure Tekni-Plex Reorganizes Business Structure
    AzurRx BioPharma Acquires First Wave Bio Inc. AzurRx BioPharma Acquires First Wave Bio Inc.
    Inhaled Drug Delivery Trends Inhaled Drug Delivery Trends
    Clinical Trial Kitting Clinical Trial Kitting
    Choosing and Managing a CDMO Choosing and Managing a CDMO
    Global Outsourcing Trends Global Outsourcing Trends
    Sanofi to Acquire Kadmon in $1.9B Deal Sanofi to Acquire Kadmon in $1.9B Deal
    Jubilant Biosys Limited Appoints Giuliano Perfetti as CEO Jubilant Biosys Limited Appoints Giuliano Perfetti as CEO
    Citius Acquires Cancer Drug Asset from Dr. Reddy Citius Acquires Cancer Drug Asset from Dr. Reddy's
    Medrio and Phastar Partner to Leverage Metadata for Advanced Data Visualization Medrio and Phastar Partner to Leverage Metadata for Advanced Data Visualization
    Arecor Therapeutics, Intas Sign Formulation Agreement Arecor Therapeutics, Intas Sign Formulation Agreement

    Related Live From Shows

    • CPhI North America Travel

      CPhI North America Travel

      ...
      04.13.23

    • Breaking News | Promotions & Moves
      Exothera Names Darren Leva as Chief Business Officer

      Exothera Names Darren Leva as Chief Business Officer

      Leva brings 20 years of broad commercial expertise to Exothera from a range of experiences with CDMOs, therapeutics, and software companies.
      02.01.23

    • Breaking News | Facilities | Industry News | Inspections
      Symbiosis Completes Successful MHRA Audit

      Symbiosis Completes Successful MHRA Audit

      Will expand facility at its Stirling, UK site with new storage and warehousing capability.
      09.16.21


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
      AGC Biologics Expands pDNA and mRNA Manufacturing Capacity

      AGC Biologics Expands pDNA and mRNA Manufacturing Capacity

      Expansion at Heidelberg site allows the CDMO to meet increasing demands of the cell and gene therapy market.
      09.14.21

    • Breaking News | Industry News
      Tekni-Plex Reorganizes Business Structure

      Tekni-Plex Reorganizes Business Structure

      Creates two key market-focused divisions: Tekni-Plex Healthcare and Tekni-Plex Consumer Products.
      09.13.21

    Loading, Please Wait..
    Breaking News
    • Univercells Expands into the U.S. With New Offices in Andover, MA
    • Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
    • Ionis, Roche Partner on RNA-targeted Programs for AD and HD
    • Sanner Group Opens Second Manufacturing Facility in China
    • Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Pharma Supply Chains: From Fragile to Agile
    • Overcoming Stressors in Knowledge Transfer
    • Innovations in Pharma Packaging
    • HPAPI Manufacturing Trends
    • Sustainable Packaging in Pharma: No Longer a Pipe Dream
    • Revolutionizing Pharma’s Supply Chain
    • Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges
    • Solving Pharma’s Underlying Rebate Leakage Problem
    • Advanced Manufacturing and a Roadmap to the Facility of the Future
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    Natrol Launches First Non-Melatonin Sleep Supplement
    Metagenics Releases Consumer Survey on Menopausal Support Supplement
    Coatings World

    Latest Breaking News From Coatings World

    California Sports Surfaces Celebrates 70 Years
    ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
    AkzoNobel Shares Sustainable Architectural Solutions at Conference
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Dentsply Sirona Names Former NuVasive CEO Lucier as Chairman
    SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
    ResMed, Nyxoah Team Up to Grow Sleep Apnea Awareness & Therapy in Germany
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Univercells Expands into the U.S. With New Offices in Andover, MA
    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
    Ionis, Roche Partner on RNA-targeted Programs for AD and HD
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    YSL Beauty Taps Finn Wolfhard, Lil Yachty & More for Fragrance Campaign
    74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
    Stoelzle Glass Group Names New CEO
    Happi

    Latest Breaking News From Happi

    The Estée Lauder Companies Launches 2023 Breast Cancer Campaign
    BASF Personal Care Introduces New Cosmetic Ingredient
    Breakfast with Oral Care Benefits?
    Ink World

    Latest Breaking News From Ink World

    Siegwerk’s Climate Targets Validated by SBTi
    ROSS Offering Cost-Effective, Expertly Reconditioned Equipment
    Amcor plc Adds Lucrèce Foufopoulos-De Ridder to Board of Directors
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    SABIC and partners launch bio-based IML solution for food packaging
    tesa completes expansion of Michigan manufacturing facility
    Comexi and Asahi to host 'Effortless Platemaking' event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Greentech Introduces Air Filter with Advanced Odor Elimination
    Ontex Divests Pakistan Operations to ASAIA Holding
    Goodnites Bedwetting Underwear Recognized by Good Housekeeping
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Lazurite Adds Benchmark Medical as a Distributor for its ArthroFree Wireless Camera System
    ChitogenX Granted New U.S., Canadian ORTHO-R Patent
    Centinel Spine prodisc System Surpasses 2,500-Implant Milestone
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
    Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More
    SCHOTT Strengthens Glass Substrate Portfolio

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login